Dr. Doug Broeska
Dr. Doug Broeska (Bra-ska) is a medical researcher having developed a protocol to treat MS and other neurodegenerative diseases through his company Regenetek Research Inc. Dr. Broeska (Bra-ska) is working from an Indian base, where patients are treated in a modern research hospital just south of Mumbai, under the local authority of an Institutional Review Board and the DCGI, the India equivalent of the FDA. Having developed safe and minimally invasive techniques to perform ‘case study’ investigations, he applied for and received authority in 2011 to perform advanced-phase human testing in India. The study is entitled: “Intravenous and Intrathecal Implantation of Adult Autologous Stem Cells for Patients with Multiple Sclerosis and other Neurodegenerative Diseases”. The approved study will use the newly-developed software to follow patients from a world-wide population base who have been treated through the protocol. Dr. Broeska (Bra-ska) also has strong ideas on the FDA’s stance on regenerative research in the US, their interpretation of biologics, what’s behind it, the use of stem cells and the unnecessary hardship this is creating in a growing patient population with these diseases.
